Get Premium to unlock powerful stock data
NAS:FWP (Denmark)  
Forward Pharma A/S logo

Forward Pharma A/S

$ 4.35 -0.15 (-3.33%) 08:08 PM EST
P/E:
At Loss
P/B:
0.43
Market Cap:
$ 30.85M
Enterprise V:
$ -39.92M
Volume:
1.01K
Avg Vol (2M):
5.65K
Also Trade In:
Volume:
1.01K
Market Cap $:
30.85M
PE Ratio:
At Loss
Avg Vol (2-Month):
5.65K
Enterprise Value $:
-39.92M
PB Ratio:
0.43
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Description
Forward Pharma A/S is a biopharmaceutical company that engages in the research and production of medicinal treatments for multiple sclerosis and psoriasis.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.99
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -3.4
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 39.16
9-Day RSI 40.31
14-Day RSI 40.54
6-1 Month Momentum % -14.57
12-1 Month Momentum % -38.26

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 117.44
Quick Ratio 117.44
Cash Ratio 116.4

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.1

Financials

FWP's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:FWP

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.28
Beta 0.83
Volatility % 36.27
14-Day RSI 40.54
14-Day ATR ($) 0.332436
20-Day SMA ($) 4.63612
12-1 Month Momentum % -38.26
52-Week Range ($) 4.02 - 20.31
Shares Outstanding (Mil) 7.09

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Forward Pharma A/S Filings

Document Form Filing Date
No Filing Data

Headlines

See More